Medicine guide

Imaavy 1200 mg/6.5 ml (185 mg/ml)

As listed in the register: Imaavy 1200 mg/6.5 ml (185 mg/ml), Konzentrat zur Herstellung einer Infusionslösung

1200 mg/6.5 ml + 185 mg/ml ·

  • Prescription only
  • Cancer treatments and immune-system medicines
Active substance
Nipocalimabum
Made by
Janssen-Cilag AG

Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.

What it is for

  • Als Zusatzbehandlung zur Standardtherapie der generalisierten Myasthenia gravis (gMG) bei Patienten ab 12 Jahren, die Anti-Acetylcholin-Rezeptor (AChR)- oder Anti-Muskelspezifische Tyrosinkinase (MuSK)-Antikörper-positiv sind.

From the official label · 2026-09-30 · Swissmedic

Same active substance, strength and form in other countries

Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.

Medicine passport: one printable page to show a pharmacist abroad

European UnionNo exact match for this strength and form

SpainNo exact match for this strength and form

CanadaNo exact match for this strength and form

Details

Made byJanssen-Cilag AG
Active substanceNipocalimabum
Used inCancer treatments and immune-system medicines
Strength1200 mg/6.5 ml + 185 mg/ml
ClassificationL04AL03 · Cancer treatments and immune-system medicines
Dispensing (as stated by the register)Abgabekategorie A
Name in the registerImaavy 1200 mg/6.5 ml (185 mg/ml), Konzentrat zur Herstellung einer Infusionslösung
Packs1 Durchstechflasche(n)
Zulassungsnummer69588
Dosisstärke2

Source: Zugelassene Packungen Humanarzneimittel · 2026-09-30 · not reviewed by a clinician

Quelle: Swissmedic. The publisher’s terms do not grant reproduction, so text is shortened and linked. Publisher’s terms.

Same active substance

These contain the same substance. That does not mean one can replace another — ask a pharmacist.